These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7691236)

  • 1. A recombinant factor VIII A2 domain polypeptide quantitatively neutralizes human inhibitor antibodies that bind to A2.
    Scandella D; Mattingly M; Prescott R
    Blood; 1993 Sep; 82(6):1767-75. PubMed ID: 7691236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.
    Scandella D; Gilbert GE; Shima M; Nakai H; Eagleson C; Felch M; Prescott R; Rajalakshmi KJ; Hoyer LW; Saenko E
    Blood; 1995 Sep; 86(5):1811-9. PubMed ID: 7544643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization.
    Scandella D; Mattingly M; de Graaf S; Fulcher CA
    Blood; 1989 Oct; 74(5):1618-26. PubMed ID: 2477082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII inhibitor antibodies with C2 domain specificity are less inhibitory to factor VIII complexed with von Willebrand factor.
    Suzuki T; Arai M; Amano K; Kagawa K; Fukutake K
    Thromb Haemost; 1996 Nov; 76(5):749-54. PubMed ID: 8950785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some human inhibitor antibodies interfere with factor VIII binding to factor IX.
    Zhong D; Saenko EL; Shima M; Felch M; Scandella D
    Blood; 1998 Jul; 92(1):136-42. PubMed ID: 9639509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of human factor VIII inhibitor antibodies by site-directed mutagenesis of a factor VIII polypeptide.
    Ware J; MacDonald MJ; Lo M; de Graaf S; Fulcher CA
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):703-16. PubMed ID: 1283342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In hemophilia A and autoantibody inhibitor patients: the factor VIII A2 domain and light chain are most immunogenic.
    Scandella DH; Nakai H; Felch M; Mondorf W; Scharrer I; Hoyer LW; Saenko EL
    Thromb Res; 2001 Mar; 101(5):377-85. PubMed ID: 11297754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble recombinant factor VIII fragment containing the A2 domain binds to some human anti-factor VIII antibodies that are not detected by immunoblotting.
    Scandella D; Timmons L; Mattingly M; Trabold N; Hoyer LW
    Thromb Haemost; 1992 Jun; 67(6):665-71. PubMed ID: 1509407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human anti-factor VIII antibodies: epitope localization and inhibitory function.
    Scandella D
    Vox Sang; 1996; 70 Suppl 1():9-14. PubMed ID: 8869462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.
    Prescott R; Nakai H; Saenko EL; Scharrer I; Nilsson IM; Humphries JE; Hurst D; Bray G; Scandella D
    Blood; 1997 May; 89(10):3663-71. PubMed ID: 9160671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity.
    Takeyama M; Nogami K; Matsumoto T; Soeda T; Suzuki T; Hattori K; Shima M
    Thromb Haemost; 2010 Jan; 103(1):94-102. PubMed ID: 20062922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
    Mizumachi K; Nakajima Y; Shimonishi N; Furukawa S; Ogiwara K; Takeyama M; Nogami K
    Haemophilia; 2024 Jan; 30(1):140-150. PubMed ID: 38058226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the human factor VIII A2 inhibitor epitope by alanine scanning mutagenesis.
    Lubin IM; Healey JF; Barrow RT; Scandella D; Lollar P
    J Biol Chem; 1997 Nov; 272(48):30191-5. PubMed ID: 9374501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of the antigenicity of factor VIII toward complex inhibitory antibody plasmas using multiply-substituted hybrid human/porcine factor VIII molecules.
    Barrow RT; Healey JF; Gailani D; Scandella D; Lollar P
    Blood; 2000 Jan; 95(2):564-8. PubMed ID: 10627463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor.
    Jacquemin M; Benhida A; Peerlinck K; Desqueper B; Vander Elst L; Lavend'homme R; d'Oiron R; Schwaab R; Bakkus M; Thielemans K; Gilles JG; Vermylen J; Saint-Remy JM
    Blood; 2000 Jan; 95(1):156-63. PubMed ID: 10607698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope specificity and inactivation mechanisms of factor VIII inhibitor antibodies.
    Scandella D
    Vox Sang; 1999; 77 Suppl 1():17-20. PubMed ID: 10529680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect.
    Nogami K; Shima M; Nakai H; Tanaka I; Suzuki H; Morichika S; Shibata M; Saenko EL; Scandella D; Giddings JC; Yoshioka A
    Br J Haematol; 1999 Oct; 107(1):196-203. PubMed ID: 10520041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
    Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
    J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and epitope specificity of anti-factor VIII C1 domain antibodies in acquired and congenital hemophilia A.
    Kahle J; Orlowski A; Stichel D; Healey JF; Parker ET; Jacquemin M; Krause M; Tiede A; Schwabe D; Lollar P; Königs C
    Blood; 2017 Aug; 130(6):808-816. PubMed ID: 28507083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.
    Sawamoto Y; Shima M; Tanaka I; Nakai H; Kamisue S; Scandella D; Yoshioka A
    Int J Hematol; 1997 Feb; 65(2):151-8. PubMed ID: 9071819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.